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The synthesis of novel heterocycles is an essential task in small-molecule drug discovery. 
Continuous flow processing opens the way for a new paradigm in laboratory-scale synthesis as 
well as pharmaceutical manufacturing. Based on our experiences with the multistep synthesis of 




The design and preparation of new heterocycles as scaffolds or building blocks for active 
pharmaceutical ingredients (APIs) is a challenging area in today’s small-molecule drug 
discovery. Chemists seek new approaches and technologies that can be applied to produce 
novel structures, while keeping an eye on increasing the efficiency and productivity of chemical 
processes. The new “enabling technologies”1,2, like flow chemistry3,4, provide practical solution 
for the synthesis of heterocyclic compounds. The emerging trends and recent synthetic results 
indicate the growing importance of continuous flow manufacturing in academia as well as 
pharmaceutical industry5–9. These efforts are also pointing towards the realization of continuous 
technologies for API synthesis10,11 in accordance with FDA’s recommendations12,13. 
However, the application of flow methods demands a paradigm shift in synthetic mentality and a 
new knowledge base, which can mean a barrier for those, who are unfamiliar with it. Our 
experience during the introduction of this technology to laboratory practice inspired us to compile 
this mini-review, to make flow chemistry more accessible. Here we discuss the problems and 
their solutions we faced during our research on the multistep synthesis of condensed 
benzothiazoles14 (Fig. 1), in the light of recent literature references. 
 
Fig. 1. Considerations for the proposed multistep continuous flow synthesis of condensed 
benzothiazoles. 
 
Heterocyclic scaffolds in drug discovery 
The development of new leads for APIs is largely based on the design and synthesis of new 
heterocycles. Applying them as building blocks, biological activity and physicochemical 
properties (like solubility, polarity and lipophilicity) of a given molecule can be modulated. In 
medicinal chemistry, the term “scaffold” is used for the core structure of a molecule, which is 
often a heterocyclic ring or ring system. In cases, when issues with these properties or the 
novelty of a specific compound series cannot be solved by modification of the side chains, the 
replacement of the central moiety (“scaffold hopping”) may become necessary, while keeping 
similar biological profile. Furthermore, the different chemical structure can lead to new 
patentable compound libraries15–17. 
Although a wide range of heterocycles are theoretically available18,19, the obtainable number and 
variety thereof is limited by the parameter window, and convenience of the synthesis20–22. In the 
preparation of such compounds with increasing complexity, the classical laboratory-scale 
methods are often difficult. Multiple steps, use of hazardous reagents, high pressure or 
temperature are usually required. These circumstances can hinder the production of the desired 
structures in large numbers. Flow chemistry, as an "enabling technology" provides new 
opportunities to broaden the chemical space. 
 
  
Design of the flow reactions 
In our recent work14 we have developed a multistep continuous flow approach for the synthesis 
of various tricyclic benzothiazoles (compounds I-V, Fig. 2). 
 
Fig. 2. The prepared tricyclic compounds. 
We intended to obtain them in three steps: (1) the preparation of the corresponding bicyclic 
compounds bearing a nitro-group, (2) the reduction of the nitro-group and (3) the formation of 
thiazole ring. Possible issues with the selection of solvent, handling of insoluble and hazardous 
reagents and the implementation of hydrogenation were taken into account during the synthesis.  
The choice of the appropriate solvent is a primary concern when designing continuous flow 
reactions. In the simplest case, a single solvent can be found which sufficiently dissolves all 
reagents, intermediates and products, and tolerates all reaction conditions. Even in this case, 
unexpected precipitation of transient species can occur, because the solubility of these 
compounds cannot be explored beforehand. Slight clogging can be flushed out if the system is 
carefully monitored. In our work, we found that N,N-dimethylformamide (DMF) could be applied 
in every step of the multistep protocol. The final step specifically required DMF, which could 
completely dissolve the products. This motivated us to switch the solvent of the hydrogenation 
step in order to simplify the whole sequence14. 
This solvent also proved to be the best option for the two-step syntheses of 5-(thiazol-2-yl)-3,4-
dihydropyrimidin-2(1H)-one derivatives23 and imidazo[1,2-a] heterocycles24. 
The high solubility of compounds and its compatibility with the integrated purification motivated 
the use of N,N-dimethylacetamide in the synthesis of 1,2,4-oxadiazole and 1,2,4-triazole 
libraries25. 
Dichloroethane was used in the telescoped synthesis of quinoxalines26. 
The replacement of the insoluble reagents, most often bases, by soluble alternatives is a 
common method to avoid clogging. N,N-diisopropylethylamine (DIPEA) is often used under flow 
conditions24,25,27. This base was successfully applied in our procedure for the synthesis of 
benzofurans and benzothiophenes, in order to replace potassium carbonate, which was used in 
batch synthesis14. While this change did not affect the synthesis of benzothiophenes negatively, 
we found that this way the alkylation reaction yielded the intermediate in the case of 
benzofurans. In order to obtain the bicyclic products, we had to use a stronger base. Verkade’s 
base (P(CH3NCH2CH2)3N) proved to be suitable in terms of the flow conditions, too
28 (Fig. 3). 
 
Fig. 3. The synthesis of benzofurans and benzothiophenes mediated by different bases. 
Several examples are reported, in which 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) is used as 
soluble stronger base29–31. Solid supported alternatives of DBU31 as well as other strong bases 
such as phosphazenes29,32, were used in heterocyclic flow synthesis. 
The safe handling of explosive or toxic reagents and the precise control of process conditions 
are two of the main benefits of flow chemistry that are getting more and more important both in 
laboratory environment and on industrial scale11,33,34. Due to the size of the microreactors, the 
actual reaction occurs only in small volume at a given time, which minimizes safety issues. 
The handling of bromine in the continuous flow ring-closure reaction leading to tricycles14 was 
safer than batch conditions, since the flow equipment can be regarded as a closed system, 
which prevents the escape of harmful vapours. 
Hazardous reagents were handled or generated in-situ in the microreactor in syntheses of other 
heterocycles. Toxic alkyl nitrite and TMS azide reagents were safely used and the resulting 
explosive azides were transformed to stable triazole products in a two-step sequence35. 
Unstable diazoketones were synthesized and used without isolation for the preparation of wide 
range of quinoxalines26. 
Flow processes are also advantageous for hydrogenations. The benchtop hydrogenation 
modules enable the safe handling of both hydrogen and the heterogeneous catalysts, most 
commonly loaded into packed bed reactors36. The separation of the catalyst from the reaction 
mixture is trivial with this setup, since it does not require additional filtration. In our work we 
utilized commercially available continuous flow hydrogenation equipment with preloaded Pd/C 
cartridges for nitro-reduction in the first step of our sequence. Due to the careful optimization37, 
sufficiently clean product (without leaching of the catalyst) was obtainable in every case, which 
helped to avoid the otherwise problematic purification of the sensitive amines14. 
Several examples of selective ring saturation, late-stage modification and protecting group 
removal can be mentioned in this context, using flow hydrogenation38–40. Similar approach was 
applied for the hydrogenation of hydrazone during the three step synthesis leading to the 
intermediate of the API Atazanavir41. 
 
Incorporation of the reactions into a continuous flow system 
One of the main goals of continuous flow processes is to perform multistep reactions in 
telescoped way. To achieve this, every single reaction parameter, chemical transformation and 
flow equipment should be taken into account. As the intermediates are not purified and isolated 
at the end of each step, all reaction steps have to be designed to be compatible with the whole 
sequence. 
In the course of our synthesis14, the aromatic amines prepared in the first steps proved to be 
unstable leading to decomposition products during purification. We realized at this point that the 
initially envisioned telescoped approach (Fig. 4) would show its benefits in this particular 
problem. This way, the outcome of the multistep system was better than the overall yield of the 
single steps. 
 Fig. 4. The multistep continuous flow synthesis of compound V. 
 
However, during investigation of the connected system we found, that utilization of the stream 
from the first step led to poorer results in the formation of the thiazole ring, compared to the 
same reaction conducted as an isolated step. 
We assumed that in this case the lack of the premixing of the amines with ammonium 
thiocyanate, which happens in the storage flask in the single step procedure, hindered the 
following reaction with bromine. Increasing the mixing time by adding a coil reactor before the 
introduction of bromine, we could obtain higher overall yields. Although, this modification 
increased the number of steps (which contributes to complexity adversely), it was 
advantageous in context of the whole process. Similar observations on the importance of the 
mixing time, in terms of the overall yield and kinetics of the reaction were made in the continuous 
flow synthesis of 4,5-disubstituted oxazoles32. 
When connecting the separately optimised steps in our work, we had to remove the hydrogen 
used in the nitro-reduction, prior to the thiazole formation. The addition of a buffer vessel to the 
reaction stream was sufficient for degassing. The same solution was employed in the multistep 
flow synthesis of Rolipram42, while other researchers tended to avoid the problem of gas 
separation and conduct hydrogenation as the last step40,41. 
 
Further implications 
Besides the above mentioned advantages, the application of flow chemistry enables the rapid 
optimization of reactions and synthesis of compound libraries together with 
automatization43,44. In our study the quick automated optimization45,46 of conditions for each 
reactions was possible14. With the appropriate setup, small volume reaction mixtures can be 
handled fast and safely, which also lowers reagent consumption of the optimization process. 
New reactions can be discovered this way, for example, novel route to the core heterocycle of 
Efavirenz was enabled by extensive screening of conditions47. 
Several analogues and larger compound libraries can be prepared, thankful to the variability of 
such systems. Numerous examples show that this concept is viable using specific, carefully 
designed and optimised fluidic setups23,29,32,35,48,49. 
 
Conclusion 
The application of flow chemistry has great perspectives in drug discovery. In order to take 
advantage of its benefits, chemists need to learn to design and build complex continuous flow 
systems. In this mini-review we have focused on the everyday challenges of laboratory-scale 
multistep flow synthesis. We aimed to present some of the design principles through our work in 
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